| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP |
| Suitable for: | Elderly, Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product Name |
Imatinib |
| CAS NO. | 152459-95-5 |
| Appearance | White Powder |
| Purity | 99% |
| Density | 1.56±0.1 g/cm3 |
Imatinib is a medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+) and certain types of gastrointestinal stromal tumors(GIST), systemic mastocytosis, and myelodysplastic syndrome.
Imatinib is mainly used for blood cell type cancers, most commonly leukemia. Imatinib is a protein kinase inhibitor, which can effectively block a variety of protein kinases and prevent the spread of cancer cells. This drug can target the highly active enzymes of cancer cells
Common side effects include vomiting, diarrhea, muscle pain, headache, and rash. Severe side effects may include fluid retention, gastrointestinal bleeding, bone marrow suppression, liver problems, and heart failure. [ Use during pregnancy may result in harm to the baby. Imatinib works by stopping the Bcr-Abl tyrosine-kinase. This can slow growth or result in programmed cell death of certain types of cancer cells.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}